{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:25:14Z","timestamp":1791285914827,"version":"4.1.0"},"reference-count":0,"publisher":"National Academy of Sciences","issue":"17","content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[1990,9]]},"abstract":"<jats:p>There is substantial evidence supporting the CD4 molecule as the principal cellular receptor for the human immunodeficiency virus type 1 (HIV-1). A number of truncated recombinant soluble CD4 (sCD4) molecules have been produced and shown to easily neutralize infection of laboratory strains of HIV-1 in vitro, and clinical trials using these sCD4 preparations have begun in patients with AIDS. Infectious HIV-1 titers in the plasma and peripheral blood mononuclear cells of five patients receiving sCD4 at 30 mg\/day were sequentially monitored. No significant decrease in viral titers was found during therapy. Furthermore, plasma samples from eight patients with AIDS were titrated for HIV-1 with and without the addition of sCD4 ex vivo. Despite the addition of sCD4 at up to 1 mg\/ml, there was little change in plasma viral titers. Subsequently, 10 primary HIV-1 isolates were tested for their susceptibility to neutralization in vitro by one preparation of sCD4. Neutralization of these clinical isolates required 200-2700 times more sCD4 than was needed to inhibit laboratory strains of HIV-1. Similar results were observed using one other monomeric sCD4 preparation and two multimeric CD4-immunoglobulin hybrid molecules. We conclude that unlike laboratory strains, primary HIV-1 isolates require high concentrations of sCD4 for neutralization. This phenomenon may pose a formidable problem for sCD4-based therapeutics in the treatment of HIV-1 infection.<\/jats:p>","DOI":"10.1073\/pnas.87.17.6574","type":"journal-article","created":{"date-parts":[[2006,5,31]],"date-time":"2006-05-31T07:24:49Z","timestamp":1149060289000},"page":"6574-6578","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":343,"title":["High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates."],"prefix":"10.1073","volume":"87","author":[{"given":"E S","family":"Daar","sequence":"first","affiliation":[{"name":"Department of Medicine, Cedars-Sinai Medical Center, University of California, Los Angeles School of Medicine 90048."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X L","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cedars-Sinai Medical Center, University of California, Los Angeles School of Medicine 90048."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Moudgil","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cedars-Sinai Medical Center, University of California, Los Angeles School of Medicine 90048."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D D","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cedars-Sinai Medical Center, University of California, Los Angeles School of Medicine 90048."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[1990,9]]},"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.87.17.6574","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T13:22:47Z","timestamp":1649856167000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.87.17.6574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,9]]},"references-count":0,"journal-issue":{"issue":"17","published-print":{"date-parts":[[1990,9]]}},"alternative-id":["10.1073\/pnas.87.17.6574"],"URL":"https:\/\/doi.org\/10.1073\/pnas.87.17.6574","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,9]]},"assertion":[{"value":"1990-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}